Interestingly, RA patients with concomitant asthma who were in remission for arthritis experienced a relapse of arthritis after treatment with mepolizumab, an IL-5-neutralizing monoclonal antibody that depletes eosinophils [58]. This evidence concerns the gene IL5 and arthritic joint disease.